title: Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster.
abstract: Withania somnifera (Ashwagandha, WS) or Indian ginseng possesses multiple pharmacological properties which are mainly attributed to the active constituents, withanolides. Despite its extensive usage as a memory enhancer and a nerve tonic, few attempts have been made to ascertain its usage in the management of Parkinson's disease. In the present study, we investigated the neuroameliorative effects of WS in a rotenone (ROT) model of Drosophila melanogaster (Oregon-K). Initially, we ascertained the ability of WS-enriched diet (0-0.05 %) to protect against ROT induced lethality and locomotor phenotype in adult male flies. Further, employing a co-exposure paradigm, we investigated the propensity of WS to offset ROT-induced oxidative stress, mitochondrial dysfunctions and neurotoxicity. WS conferred significant protection against ROT-induced lethality, while the survivor flies exhibited improved locomotor phenotype. Biochemical investigations revealed that ROT-induced oxidative stress was significantly diminished by WS enrichment. WS caused significant elevation in the levels of reduced GSH/non-protein thiols. Furthermore, the altered activity levels of succinate dehydrogenase, MTT, membrane bound enzymes viz., NADH-cytochrome-c reductase and succinate-cytochrome-c reductase were markedly restored to normalcy. Interestingly, ROT-induced perturbations in cholinergic function and depletion in dopamine levels were normalized by WS. Taken together these data suggests that the neuromodulatory effect of WS against ROT- induced neurotoxicity is probably mediated via suppression of oxidative stress and its potential to attenuate mitochondrial dysfunctions. Our further studies aim to understand the underlying neuroprotective mechanisms of WS and withanolides employing neuronal cell models.
authors.affiliation: Department of Biochemistry and Nutrition, CSIR- Central Food Technological Research Institute (CFTRI), Mysore, 570020 India.
authors.forename: M J
authors.initials: MJ
authors.lastname: Manjunath
authors.affiliation: Department of Biochemistry and Nutrition, CSIR- Central Food Technological Research Institute (CFTRI), Mysore, 570020 India.
authors.lastname: Muralidhara
keywords: Drosophila melanogaster; Mitochondrial dysfunctions; Oxidative stress; Parkinson’s disease; Rotenone; Withania somnifera
references.citation: Neurotoxicology. 2009 Nov;30(6):977-85
references.pmid: 19744517
references.citation: Free Radic Biol Med. 2011 Apr 1;50(7):899-902
references.pmid: 21145387
references.citation: Br J Pharmacol. 2005 Apr;144(7):961-71
references.pmid: 15711595
references.citation: Drug Discov Today. 2005 Apr 1;10(7):495-502
references.pmid: 15809195
references.citation: Chem Pharm Bull (Tokyo). 2002 Jun;50(6):760-5
references.pmid: 12045329
references.citation: Prog Neurobiol. 2000 Dec;62(6):649-71
references.pmid: 10880854
references.citation: J Med Food. 2009 Jun;12(3):591-600
references.pmid: 19627208
references.citation: Neurotoxicology. 2012 Jun;33(3):444-56
references.pmid: 22521218
references.citation: Mov Disord. 2007 Oct 15;22(13):1901-11
references.pmid: 17674410
references.citation: Neurochem Res. 2009 Nov;34(11):1975-83
references.pmid: 19444606
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R985-92
references.pmid: 11893601
references.citation: Anal Biochem. 1984 Aug 1;140(2):506-9
references.pmid: 6486436
references.citation: Methods Enzymol. 1984;105:121-6
references.pmid: 6727660
references.citation: J Neurosci. 2004 Dec 1;24(48):10993-8
references.pmid: 15574749
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1093-105
references.pmid: 17959291
references.citation: Int J Pharm. 2007 May 4;336(1):133-9
references.pmid: 17184941
references.citation: Indian J Biochem Biophys. 2010 Apr;47(2):75-82
references.pmid: 20521619
references.citation: Toxicology. 2010 Jun 4;272(1-3):17-22
references.pmid: 20371261
references.citation: Neurochem Res. 2010 Sep;35(9):1402-12
references.pmid: 20514516
references.citation: J Biosci. 2003 Feb;28(1):121-8
references.pmid: 12682435
references.citation: Neurobiol Dis. 2010 Oct;40(1):82-92
references.pmid: 20483372
references.citation: Biochem Biophys Res Commun. 2005 Aug 19;334(1):276-87
references.pmid: 16108094
references.citation: Phytother Res. 2006 Jul;20(7):538-41
references.pmid: 16691632
references.citation: Neuroreport. 2000 Jun 26;11(9):1981-5
references.pmid: 10884056
references.citation: Cell Mol Biol Lett. 2007;12(4):473-81
references.pmid: 17415533
references.citation: Mov Disord. 2012 May;27(6):727-34
references.pmid: 22410753
references.citation: Arch Biochem Biophys. 1959 May;82(1):70-7
references.pmid: 13650640
references.citation: CNS Neurol Disord Drug Targets. 2010 Aug;9(4):504-23
references.pmid: 20522007
references.citation: Biochem Int. 1989 Nov;19(5):1117-24
references.pmid: 2561443
references.citation: Methods Enzymol. 1985;113:507-10
references.pmid: 4088072
references.citation: Neurotoxicology. 2013 Jul;37:118-26
references.pmid: 23639798
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1104-14
references.pmid: 20547199
references.citation: Anal Biochem. 1979 Jun;95(2):351-8
references.pmid: 36810
references.citation: Nature. 2000 Mar 23;404(6776):394-8
references.pmid: 10746727
references.citation: Hum Exp Toxicol. 2005 Mar;24(3):137-47
references.pmid: 15901053
references.citation: Cent Nerv Syst Agents Med Chem. 2013 Mar;13(1):43-56
references.pmid: 23092410
references.citation: Free Radic Biol Med. 2013 Sep;62:13-25
references.pmid: 23665395
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: Biomed Pharmacother. 2008 Apr-May;62(4):236-49
references.pmid: 18400456
references.citation: Neuroscience. 2013 Aug 29;246:382-90
references.pmid: 23623990
references.citation: Prog Brain Res. 2010;184:17-33
references.pmid: 20887868
references.citation: Environ Health Perspect. 2011 Jun;119(6):A259
references.pmid: 21628118
references.citation: Methods Enzymol. 1996;264:484-509
references.pmid: 8965721
references.citation: Neurotoxicol Teratol. 2010 Jan-Feb;32(1):74-83
references.pmid: 19559084
references.citation: J Neurosci. 2003 Nov 26;23(34):10756-64
references.pmid: 14645467
references.citation: Neurotoxicology. 2012 Oct;33(5):1254-64
references.pmid: 22841601
references.citation: Trends Pharmacol Sci. 2009 Sep;30(9):475-83
references.pmid: 19729209
references.citation: Neurotoxicology. 2008 Nov;29(6):948-57
references.pmid: 18930762
references.citation: Biochem Pharmacol. 1961 Jul;7:88-95
references.pmid: 13726518
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Mar;286(3):R505-11
references.pmid: 14615275